Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Conditions

• Chronic Obstructive Pulmonary Disease

Interventions

• DRUG: SAR440340
• DRUG: Placebo
• DRUG: Any Inhaled Corticosteroids as prescribed by treating physician as standard of care
• DRUG: Any Long Acting Beta Agonist as prescribed by treating physician as standard of care
• DRUG: Any Long Acting Muscarinic Agonist as prescribed by treating physician as standard of care
• DRUG: Any short-acting β agonist as prescribed by treating physician as standard of care

Sponsor

Sanofi

Collaborators

• [object Object]